Global and Japan Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Sep-2020
No. of pages: 130
Inquire Before Buying

Congestive Heart Failure (CHF) Treatment Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Congestive Heart Failure (CHF) Treatment Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into

- Cardiac Resynchronization Therapy (CRT)

- Implantable Cardioverter Defibrillators (ICDs)

Segment by Application, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into

- Left Ventricular Assist Device (LVAD)

- Right Ventricular Assist Device (RVAD)

- Biventricular Assist Device (BIVAD)

Regional and Country-level Analysis

The Congestive Heart Failure (CHF) Treatment Devices market is analysed and market size information is provided by regions (countries).

The key regions covered in the Congestive Heart Failure (CHF) Treatment Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Congestive Heart Failure (CHF) Treatment Devices Market Share Analysis

Congestive Heart Failure (CHF) Treatment Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Congestive Heart Failure (CHF) Treatment Devices business, the date to enter into the Congestive Heart Failure (CHF) Treatment Devices market, Congestive Heart Failure (CHF) Treatment Devices product introduction, recent developments, etc.

The major vendors covered:

- Abiomed

- Berlin Heart GmbH

- Biotronik SE & Co. KG

- Boston Scientific Corporation

- HeartWare International

- Jarvik Heart

- LivaNova PLC

- Medtronic

- ReliantHeart

- Abbott

Global and Japan Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
1.2 Market Segments
1.3 Key Congestive Heart Failure (CHF) Treatment Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type
1.4.2 Cardiac Resynchronization Therapy (CRT)
1.4.3 Implantable Cardioverter Defibrillators (ICDs)
1.5 Market by Application
1.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application
1.5.2 Left Ventricular Assist Device (LVAD)
1.5.3 Right Ventricular Assist Device (RVAD)
1.5.4 Biventricular Assist Device (BIVAD)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Estimates and Forecasts
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2015-2026
2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2015-2026
2.2 Global Congestive Heart Failure (CHF) Treatment Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Congestive Heart Failure (CHF) Treatment Devices Historical Market Size by Region (2015-2020)
2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2021-2026)
2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2021-2026)
3 Global Congestive Heart Failure (CHF) Treatment Devices Competitor Landscape by Players
3.1 Global Top Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2015-2020)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2015-2020)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2019
3.2.5 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers
3.4 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Product Types
3.4.1 Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
3.4.3 Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type (2015-2020)
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020)
4.1.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
4.2.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application (2015-2020)
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020)
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2015-2020)
5.1.3 Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
5.2 Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
6.1.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales YoY Growth 2015-2026
6.1.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue YoY Growth 2015-2026
6.1.3 Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2015-2026
6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size by Players (International and Local Players)
6.2.1 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Sales (2015-2020)
6.2.2 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Revenue (2015-2020)
6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Type (2015-2020)
6.3.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2015-2020)
6.3.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2015-2020)
6.3.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Type (2015-2020)
6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
6.4.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
6.4.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2021-2026)
6.5 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Application (2015-2020)
6.5.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
6.5.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
6.5.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
6.6 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)
7 North America
7.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
7.2 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
7.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020)
7.2.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
8.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
8.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country
8.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
9.2.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2015-2020)
9.2.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
10.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
10.2.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
10.2.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country
11.2.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abiomed
12.1.1 Abiomed Corporation Information
12.1.2 Abiomed Description and Business Overview
12.1.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.1.5 Abiomed Recent Development
12.2 Berlin Heart GmbH
12.2.1 Berlin Heart GmbH Corporation Information
12.2.2 Berlin Heart GmbH Description and Business Overview
12.2.3 Berlin Heart GmbH Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.2.5 Berlin Heart GmbH Recent Development
12.3 Biotronik SE & Co. KG
12.3.1 Biotronik SE & Co. KG Corporation Information
12.3.2 Biotronik SE & Co. KG Description and Business Overview
12.3.3 Biotronik SE & Co. KG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.3.5 Biotronik SE & Co. KG Recent Development
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Corporation Information
12.4.2 Boston Scientific Corporation Description and Business Overview
12.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.4.5 Boston Scientific Corporation Recent Development
12.5 HeartWare International
12.5.1 HeartWare International Corporation Information
12.5.2 HeartWare International Description and Business Overview
12.5.3 HeartWare International Sales, Revenue and Gross Margin (2015-2020)
12.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.5.5 HeartWare International Recent Development
12.6 Jarvik Heart
12.6.1 Jarvik Heart Corporation Information
12.6.2 Jarvik Heart Description and Business Overview
12.6.3 Jarvik Heart Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.6.5 Jarvik Heart Recent Development
12.7 LivaNova PLC
12.7.1 LivaNova PLC Corporation Information
12.7.2 LivaNova PLC Description and Business Overview
12.7.3 LivaNova PLC Sales, Revenue and Gross Margin (2015-2020)
12.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.7.5 LivaNova PLC Recent Development
12.8 Medtronic
12.8.1 Medtronic Corporation Information
12.8.2 Medtronic Description and Business Overview
12.8.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.8.5 Medtronic Recent Development
12.9 ReliantHeart
12.9.1 ReliantHeart Corporation Information
12.9.2 ReliantHeart Description and Business Overview
12.9.3 ReliantHeart Sales, Revenue and Gross Margin (2015-2020)
12.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.9.5 ReliantHeart Recent Development
12.10 Abbott
12.10.1 Abbott Corporation Information
12.10.2 Abbott Description and Business Overview
12.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.10.5 Abbott Recent Development
12.11 Abiomed
12.11.1 Abiomed Corporation Information
12.11.2 Abiomed Description and Business Overview
12.11.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.11.5 Abiomed Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Congestive Heart Failure (CHF) Treatment Devices Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Congestive Heart Failure (CHF) Treatment Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Congestive Heart Failure (CHF) Treatment Devices Market Segments
Table 2. Ranking of Global Top Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cardiac Resynchronization Therapy (CRT)
Table 5. Major Manufacturers of Implantable Cardioverter Defibrillators (ICDs)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Regions 2015-2020 (K Units)
Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions (2015-2020)
Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2015-2020)
Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2019)
Table 16. Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Price (2015-2020) (USD/Unit)
Table 19. Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
Table 21. Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020) (K Units)
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2015-2020)
Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2015-2020)
Table 27. Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2021-2026)
Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020) (K Units)
Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2015-2020)
Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2021-2026)
Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2015-2020)
Table 37. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2015-2020)
Table 39. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2015-2020)
Table 40. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Congestive Heart Failure (CHF) Treatment Devices Price (K Units) by Type (2015-2020)
Table 42. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2021-2026)
Table 43. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2021-2026)
Table 44. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2021-2026)
Table 46. Japan Congestive Heart Failure (CHF) Treatment Devices Price (K Units) by Type (2021-2026)
Table 47. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2015-2020)
Table 48. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2015-2020)
Table 49. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2021-2026)
Table 51. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2021-2026)
Table 52. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2021-2026)
Table 54. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 55. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 56. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 58. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 59. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2015-2020)
Table 66. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 67. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 74. Abiomed Corporation Information
Table 75. Abiomed Description and Business Overview
Table 76. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product
Table 78. Abiomed Recent Development
Table 79. Berlin Heart GmbH Corporation Information
Table 80. Berlin Heart GmbH Description and Business Overview
Table 81. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Berlin Heart GmbH Product
Table 83. Berlin Heart GmbH Recent Development
Table 84. Biotronik SE & Co. KG Corporation Information
Table 85. Biotronik SE & Co. KG Description and Business Overview
Table 86. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Biotronik SE & Co. KG Product
Table 88. Biotronik SE & Co. KG Recent Development
Table 89. Boston Scientific Corporation Corporation Information
Table 90. Boston Scientific Corporation Description and Business Overview
Table 91. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Boston Scientific Corporation Product
Table 93. Boston Scientific Corporation Recent Development
Table 94. HeartWare International Corporation Information
Table 95. HeartWare International Description and Business Overview
Table 96. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. HeartWare International Product
Table 98. HeartWare International Recent Development
Table 99. Jarvik Heart Corporation Information
Table 100. Jarvik Heart Description and Business Overview
Table 101. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Jarvik Heart Product
Table 103. Jarvik Heart Recent Development
Table 104. LivaNova PLC Corporation Information
Table 105. LivaNova PLC Description and Business Overview
Table 106. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. LivaNova PLC Product
Table 108. LivaNova PLC Recent Development
Table 109. Medtronic Corporation Information
Table 110. Medtronic Description and Business Overview
Table 111. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Medtronic Product
Table 113. Medtronic Recent Development
Table 114. ReliantHeart Corporation Information
Table 115. ReliantHeart Description and Business Overview
Table 116. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. ReliantHeart Product
Table 118. ReliantHeart Recent Development
Table 119. Abbott Corporation Information
Table 120. Abbott Description and Business Overview
Table 121. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Abbott Product
Table 123. Abbott Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Congestive Heart Failure (CHF) Treatment Devices Players
Table 128. Congestive Heart Failure (CHF) Treatment Devices Customers List
Table 129. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Cardiac Resynchronization Therapy (CRT) Product Picture
Figure 4. Implantable Cardioverter Defibrillators (ICDs) Product Picture
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2020 & 2026
Figure 6. Left Ventricular Assist Device (LVAD)
Figure 7. Right Ventricular Assist Device (RVAD)
Figure 8. Biventricular Assist Device (BIVAD)
Figure 9. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size 2015-2026 (US$ Million)
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2015-2026 (K Units)
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2015-2020)
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2019
Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2015-2020)
Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2019
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2019
Figure 19. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2015-2020)
Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2019
Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2015-2020)
Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type in 2019
Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Price Range (2015-2020)
Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2019
Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
Figure 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application in 2019
Figure 29. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2026 (K Units)
Figure 30. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue in Congestive Heart Failure (CHF) Treatment Devices in 2019
Figure 33. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2015-2020)
Figure 34. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2015-2020)
Figure 36. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 40. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 41. U.S. Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 48. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 49. Germany Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Congestive Heart Failure (CH
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs